EC Healthcare (UNHLF)
- Previous Close
0.1657 - Open
0.1657 - Bid --
- Ask --
- Day's Range
0.1657 - 0.1657 - 52 Week Range
0.1657 - 0.8193 - Volume
64 - Avg. Volume
16 - Market Cap (intraday)
202.89M - Beta (5Y Monthly) 1.31
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield 0.00 (0.77%)
- Ex-Dividend Date Dec 28, 2023
- 1y Target Est
--
EC Healthcare, an investment holding company, engages in the provision of medical and healthcare services in Hong Kong, Macau, and the People's Republic of China. The company operates through three segments: Medical, Aesthetic Medical and Beauty and Wellness, Veterinary and Others. It provides quasi-medical, beauty and wellness, medical imaging, medical surgery, aesthetic medical beauty, aesthetic medical, dental, hair treatment, vaccine, chiropractic, psychological, and orthopedics services. It also offers administrative, management, laboratory testing, performance marketing, marketing, and travel agency services; sells beauty and skincare products; operates in healthcare machines and property investment holding businesses; and provides multi-channel networking and related services, and veterinary services. The company offers products and services primarily under private-label brands, such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. The company was formerly known as Union Medical Healthcare Limited and changed its name to EC Healthcare in April 2021. The company was founded in 2005 and is headquartered in Mong Kok, Hong Kong.
www.echealthcare.com2,715
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: UNHLF
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UNHLF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UNHLF
Valuation Measures
Market Cap
202.89M
Enterprise Value
315.59M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.37
Price/Book (mrq)
0.82
Enterprise Value/Revenue
0.08
Enterprise Value/EBITDA
0.44
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.09%
Return on Assets (ttm)
0.98%
Return on Equity (ttm)
0.97%
Revenue (ttm)
4.1B
Net Income Avi to Common (ttm)
-3.74M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
705M
Total Debt/Equity (mrq)
63.74%
Levered Free Cash Flow (ttm)
473.86M
Company Insights: UNHLF
UNHLF does not have Company Insights